MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/24/2026ACC: 0002012524-26-000008
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-6.26K
Net shares
Net seller
$106.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.26K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−6.26K
Price / share
$16.95
Trade value
$106.07K
% of position
3.2%
8/20/2026
196.08K→189.83K
Total
Net shares
−6.26K
Net value
-$106.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2026 | F · Tax Withholding | −6.26K | $16.95 | $106.07K | 3.2% | 196.08K | 189.83K |
| Total | −6.26K | -$106.07K | ||||||
Derivative Transactions0
No derivative transactions reported